{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T05:47:37Z","timestamp":1784008057928,"version":"3.55.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":2165,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T00:00:00Z","timestamp":1582934400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001250","name":"Morris Animal Foundation","doi-asserted-by":"publisher","award":["D14CA-810"],"award-info":[{"award-number":["D14CA-810"]}],"id":[{"id":"10.13039\/100001250","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Florida Open Access Publishing Fund"},{"DOI":"10.13039\/100001250","name":"Morris Animal Foundation","doi-asserted-by":"publisher","award":["D14CA\u2010810"],"award-info":[{"award-number":["D14CA\u2010810"]}],"id":[{"id":"10.13039\/100001250","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>An angiotensin-converting enzyme (ACE) gene polymorphism occurs in dogs; however, functional importance is not well studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>We hypothesized that dogs with the polymorphism would show alternative renin-angiotensin aldosterone system (RAAS) pathway activation and classical RAAS pathway suppression before and after ACE-inhibitor administration, as compared to dogs without the polymorphism that would show this pattern only after ACE-inhibitor administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Twenty-one dogs with mitral valve disease that were genotyped for the ACE gene polymorphism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study utilized stored samples from 8 ACE gene polymorphism-negative (PN) dogs and 13 ACE gene polymorphism-positive (PP) dogs before and after enalapril administration. Equilibrium analysis was performed to evaluate serum RAAS metabolites and enzyme activities. Results were compared before and after enalapril, and between groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The classical RAAS pathway was suppressed and the alternative RAAS pathway was enhanced for both genotypes after administration of enalapril, with no differences before enalapril administration. Aldosterone breakthrough occurred in both PN (38%) and PP (54%) dogs despite angiotensin II suppression. Aldosterone was significantly higher (P = .02) in ACE gene PP dogs (median, 92.17 pM; IQR, 21.85-184.70) compared to ACE gene PN dogs (median, 15.91 pM; IQR, &amp;lt;15.00-33.92) after enalapril.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>The ACE gene polymorphism did not alter baseline RAAS activity. Aldosterone breatkthrough in some dogs suggests nonangiotensin mediated aldosterone production that might be negatively influenced by genotype. These results support the use of aldosterone receptor antagonists with ACE-inhibitors when RAAS inhibition is indicated for dogs, especially those positive for the ACE gene polymorphism.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.15746","type":"journal-article","created":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T05:55:16Z","timestamp":1582955716000},"page":"600-606","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism"],"prefix":"10.1093","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0972-0365","authenticated-orcid":false,"given":"Darcy","family":"Adin","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, University of Florida , Gainesville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarke","family":"Atkins","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, North Carolina State University , Raleigh, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Domenig","sequence":"additional","affiliation":[{"name":"Attoquant Diagnostics , Vienna,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3663-3323","authenticated-orcid":false,"given":"Teresa","family":"DeFrancesco","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, North Carolina State University , Raleigh, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Keene","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, North Carolina State University , Raleigh, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Tou","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, North Carolina State University , Raleigh, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Stern","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, University of California Department of Medicine and Epidemiology, , Davis, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Meurs","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, North Carolina State University , Raleigh, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,1]]},"reference":[{"key":"2026020302550310000_jvim15746-bib-0001","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jvim.15454","article-title":"The renin-angiotensin-aldosterone system and its suppression","volume":"33","author":"Ames","year":"2019","journal-title":"J Vet Intern Med"},{"key":"2026020302550310000_jvim15746-bib-0002","first-page":"829","article-title":"Aldosterone and mineralocorticoid receptors in regulation of the cardiovascular system and pathological remodelling of the heart and arteries","volume":"69","author":"Sztechman","year":"2018","journal-title":"J Physiol Pharmacol"},{"key":"2026020302550310000_jvim15746-bib-0003","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1152\/ajprenal.00455.2004","article-title":"Contribution of the basolaferal isoform of the Na-K-2Cl- cotransporter (NKCC1\/BSC2) to renin secretion","volume":"289","author":"Castrop","year":"2005","journal-title":"Am J Physiol - Ren Physiol"},{"key":"2026020302550310000_jvim15746-bib-0004","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.cvsm.2004.05.005","article-title":"Neuroendocrine evaluation of cardiac disease","volume":"34","author":"Sisson","year":"2004","journal-title":"Vet Clin North Am - Small Anim Pract"},{"key":"2026020302550310000_jvim15746-bib-0005","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2460\/ajvr.68.10.1045","article-title":"Modulation of the tissue renin-angiotensin-aldosterone system in dogs with chronic mild regurgitation through the mitral valve","volume":"68","author":"Fujii","year":"2007","journal-title":"Am J Vet Res"},{"key":"2026020302550310000_jvim15746-bib-0006","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1939-1676.1995.tb01075.x","article-title":"Controlled clinical evaluation of Enalapril in dogs with heart failure: results of the cooperative veterinary Enalapril study group","volume":"9","author":"The Cove Study Group","year":"1995","journal-title":"J Vet Intern Med"},{"key":"2026020302550310000_jvim15746-bib-0007","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1939-1676.1995.tb01074.x","article-title":"Acute and short-term hemodynamic, echocardiographic, and clinical effects of Enalapril maleate in dogs with naturally acquired heart failure:-results of the invasive multicenter PROspective veterinary evaluation of Enalapril study","volume":"9","author":"The IMPROVE Study Group","year":"1995","journal-title":"J Vet Intern Med"},{"key":"2026020302550310000_jvim15746-bib-0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep33678","article-title":"Neprilysin is a mediator of alternative renin-angiotensin-system activation in the murine and human kidney","volume":"6","author":"Domenig","year":"2016","journal-title":"Sci Rep"},{"key":"2026020302550310000_jvim15746-bib-0009","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/07853890.2017.1313447","article-title":"Effects of direct renin inhibition versus angiotensin II receptor blockade on angiotensin profiles in non-diabetic chronic kidney disease","volume":"49","author":"Antlanger","year":"2017","journal-title":"Ann Med"},{"key":"2026020302550310000_jvim15746-bib-0010","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jacc.2016.11.064","article-title":"Roles of angiotensin peptides and recombinant human ACE2 in heart failure","volume":"69","author":"Basu","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026020302550310000_jvim15746-bib-0011","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/jvim.15548","article-title":"Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease","volume":"33","author":"Larouche-Lebel","year":"2019","journal-title":"J Vet Intern Med"},{"key":"2026020302550310000_jvim15746-bib-0012","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.RES.0000223145.74217.e7","article-title":"ACE polymorphisms","volume":"98","author":"Sayed-Tabatabaei","year":"2006","journal-title":"Circ Res"},{"key":"2026020302550310000_jvim15746-bib-0013","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/FPC.0000000000000322","article-title":"Angiotensin-converting enzyme activity in cavalier king Charles spaniels with an ACE gene polymorphism and myxomatous mitral valve disease","volume":"28","author":"Meurs","year":"2018","journal-title":"Pharmacogenet Genomics"},{"key":"2026020302550310000_jvim15746-bib-0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1470320317737184","article-title":"Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism","volume":"18","author":"Meurs","year":"2017","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2026020302550310000_jvim15746-bib-0015","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/1470320314568438","article-title":"Pharmacodynamic effects of C-domain specific ACE inhibitors on the renin angiotensin system in myocardial infarcted rats","volume":"16","author":"Sharp","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2026020302550310000_jvim15746-bib-0016","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/vr.148.23.707","article-title":"Use of breed-specific ranges for the vertebral heart scale as an aid to the radiographic diagnosis of cardiac disease in dogs","volume":"148","author":"Lamb","year":"2001","journal-title":"Vet Rec"},{"key":"2026020302550310000_jvim15746-bib-0017","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1373\/clinchem.2017.278705","article-title":"Low-and high-renin heart failure phenotypes with clinical implications","volume":"64","author":"Pavo","year":"2018","journal-title":"Clin Chem"},{"key":"2026020302550310000_jvim15746-bib-0018","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/ncpneph0575","article-title":"The incidence and implications of aldosterone breakthrough","volume":"3","author":"Bomback","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"2026020302550310000_jvim15746-bib-0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/prp2.131","article-title":"Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses","volume":"3","author":"Keizer","year":"2015","journal-title":"Pharmacol Res Perspect"},{"key":"2026020302550310000_jvim15746-bib-0020","first-page":"303","article-title":"Values below detection limit in compositional chemical data","volume":"764","author":"Ogden","year":"2019","journal-title":"Pharmacogenet Genomics"},{"key":"2026020302550310000_jvim15746-bib-0021","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jvc.2017.03.001","article-title":"Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease","volume":"19","author":"Ames","year":"2017","journal-title":"J Vet Cardiol"},{"key":"2026020302550310000_jvim15746-bib-0022","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/bs.vh.2018.10.001","article-title":"Paracrine regulation of aldosterone secretion in physiological and pathophysiological conditions","volume":"109","author":"Lefebvre","year":"2019","journal-title":"Vitam Horm"},{"key":"2026020302550310000_jvim15746-bib-0023","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1021\/acs.analchem.8b03828","article-title":"The plethora of angiotensin-converting enzyme-processed peptides in mouse plasma","volume":"91","author":"Semis","year":"2019","journal-title":"Anal Chem"},{"key":"2026020302550310000_jvim15746-bib-0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1470320316633897","article-title":"Evaluation of subacute change in RAAS activity (as indicated by urinary aldosterone:creatinine, after pharmacologic provocation) and the response to ACE inhibition","volume":"17","author":"Ames","year":"2016","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2026020302550310000_jvim15746-bib-0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1939-1676.2002.tb01610.x","article-title":"Efficacy of Enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation","volume":"16","author":"Kvart","year":"2002","journal-title":"J Vet Intern Med"},{"key":"2026020302550310000_jvim15746-bib-0026","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2460\/javma.231.7.1061","article-title":"Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency","volume":"231","author":"Atkins","year":"2007","journal-title":"J Am Vet Med Assoc"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.15746","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvim.15746","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvim.15746","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/34\/2\/600\/66661669\/jvim15746.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/34\/2\/600\/66661669\/jvim15746.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T07:55:14Z","timestamp":1770105314000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/34\/2\/600\/8448448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.15746","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3]]},"published":{"date-parts":[[2020,3,1]]},"assertion":[{"value":"2019-10-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}